165 related articles for article (PubMed ID: 30827244)
21. Pharmacophore Identification and Scaffold Exploration to Discover Novel, Potent, and Chemically Stable Inhibitors of Acid Ceramidase in Melanoma Cells.
Ortega JA; Arencibia JM; La Sala G; Borgogno M; Bauer I; Bono L; Braccia C; Armirotti A; Girotto S; Ganesan A; De Vivo M
J Med Chem; 2017 Jul; 60(13):5800-5815. PubMed ID: 28603987
[TBL] [Abstract][Full Text] [Related]
22. Potential role of acid ceramidase in conversion of cytostatic to cytotoxic end-point in pancreatic cancer cells.
Morad SA; Messner MC; Levin JC; Abdelmageed N; Park H; Merrill AH; Cabot MC
Cancer Chemother Pharmacol; 2013 Mar; 71(3):635-45. PubMed ID: 23263160
[TBL] [Abstract][Full Text] [Related]
23. Acid Ceramidase in Melanoma: EXPRESSION, LOCALIZATION, AND EFFECTS OF PHARMACOLOGICAL INHIBITION.
Realini N; Palese F; Pizzirani D; Pontis S; Basit A; Bach A; Ganesan A; Piomelli D
J Biol Chem; 2016 Jan; 291(5):2422-34. PubMed ID: 26553872
[TBL] [Abstract][Full Text] [Related]
24. C6-ceramide and targeted inhibition of acid ceramidase induce synergistic decreases in breast cancer cell growth.
Flowers M; Fabriás G; Delgado A; Casas J; Abad JL; Cabot MC
Breast Cancer Res Treat; 2012 Jun; 133(2):447-58. PubMed ID: 21935601
[TBL] [Abstract][Full Text] [Related]
25. Acid ceramidase upregulation in prostate cancer cells confers resistance to radiation: AC inhibition, a potential radiosensitizer.
Mahdy AE; Cheng JC; Li J; Elojeimy S; Meacham WD; Turner LS; Bai A; Gault CR; McPherson AS; Garcia N; Beckham TH; Saad A; Bielawska A; Bielawski J; Hannun YA; Keane TE; Taha MI; Hammouda HM; Norris JS; Liu X
Mol Ther; 2009 Mar; 17(3):430-8. PubMed ID: 19107118
[TBL] [Abstract][Full Text] [Related]
26. Acid ceramidase is associated with an improved prognosis in both DCIS and invasive breast cancer.
Sänger N; Ruckhäberle E; Györffy B; Engels K; Heinrich T; Fehm T; Graf A; Holtrich U; Becker S; Karn T
Mol Oncol; 2015 Jan; 9(1):58-67. PubMed ID: 25131496
[TBL] [Abstract][Full Text] [Related]
27. Acute activation of acid ceramidase affects cytokine-induced cytotoxicity in rat islet beta-cells.
Zhu Q; Shan X; Miao H; Lu Y; Xu J; You N; Liu C; Liao DF; Jin J
FEBS Lett; 2009 Jun; 583(12):2136-41. PubMed ID: 19497324
[TBL] [Abstract][Full Text] [Related]
28. Acid ceramidase 1 expression correlates with a better prognosis in ER-positive breast cancer.
Ruckhäberle E; Holtrich U; Engels K; Hanker L; Gätje R; Metzler D; Karn T; Kaufmann M; Rody A
Climacteric; 2009 Dec; 12(6):502-13. PubMed ID: 19905902
[TBL] [Abstract][Full Text] [Related]
29. Complete Acid Ceramidase ablation prevents cancer-initiating cell formation in melanoma cells.
Lai M; Realini N; La Ferla M; Passalacqua I; Matteoli G; Ganesan A; Pistello M; Mazzanti CM; Piomelli D
Sci Rep; 2017 Aug; 7(1):7411. PubMed ID: 28785021
[TBL] [Abstract][Full Text] [Related]
30. Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse.
Cheng JC; Bai A; Beckham TH; Marrison ST; Yount CL; Young K; Lu P; Bartlett AM; Wu BX; Keane BJ; Armeson KE; Marshall DT; Keane TE; Smith MT; Jones EE; Drake RR; Bielawska A; Norris JS; Liu X
J Clin Invest; 2013 Oct; 123(10):4344-58. PubMed ID: 24091326
[TBL] [Abstract][Full Text] [Related]
31. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids.
Gatt S; Dagan A
Chem Phys Lipids; 2012 May; 165(4):462-74. PubMed ID: 22387097
[TBL] [Abstract][Full Text] [Related]
32. Tamoxifen is a candidate first-in-class inhibitor of acid ceramidase that reduces amitotic division in polyploid giant cancer cells-Unrecognized players in tumorigenesis.
White-Gilbertson S; Lu P; Jones CM; Chiodini S; Hurley D; Das A; Delaney JR; Norris JS; Voelkel-Johnson C
Cancer Med; 2020 May; 9(9):3142-3152. PubMed ID: 32135040
[TBL] [Abstract][Full Text] [Related]
33. Acid Ceramidase Depletion Impairs Neuronal Survival and Induces Morphological Defects in Neurites Associated with Altered Gene Transcription and Sphingolipid Content.
Kyriakou K; Lederer CW; Kleanthous M; Drousiotou A; Malekkou A
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32111095
[TBL] [Abstract][Full Text] [Related]
34. Development of an acid ceramidase activity-based probe.
Ouairy CM; Ferraz MJ; Boot RG; Baggelaar MP; van der Stelt M; Appelman M; van der Marel GA; Florea BI; Aerts JM; Overkleeft HS
Chem Commun (Camb); 2015 Apr; 51(28):6161-3. PubMed ID: 25748248
[TBL] [Abstract][Full Text] [Related]
35. Sphingolipids and response to chemotherapy.
Dimanche-Boitrel MT; Rebillard A
Handb Exp Pharmacol; 2013; (216):73-91. PubMed ID: 23563652
[TBL] [Abstract][Full Text] [Related]
36. Acid ceramidase, a double-edged sword in cancer aggression: A minireview.
Vethakanraj HS; Chandrasekaran N; Sekar AK
Curr Cancer Drug Targets; 2020 Dec; ():. PubMed ID: 33357194
[TBL] [Abstract][Full Text] [Related]
37. Anticancer actions of lysosomally targeted inhibitor, LCL521, of acid ceramidase.
Bai A; Mao C; Jenkins RW; Szulc ZM; Bielawska A; Hannun YA
PLoS One; 2017; 12(6):e0177805. PubMed ID: 28614356
[TBL] [Abstract][Full Text] [Related]
38. Autophagy is increased in prostate cancer cells overexpressing acid ceramidase and enhances resistance to C6 ceramide.
Turner LS; Cheng JC; Beckham TH; Keane TE; Norris JS; Liu X
Prostate Cancer Prostatic Dis; 2011 Mar; 14(1):30-7. PubMed ID: 21116286
[TBL] [Abstract][Full Text] [Related]
39. Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity.
Realini N; Solorzano C; Pagliuca C; Pizzirani D; Armirotti A; Luciani R; Costi MP; Bandiera T; Piomelli D
Sci Rep; 2013; 3():1035. PubMed ID: 23301156
[TBL] [Abstract][Full Text] [Related]
40. Acid ceramidase regulates innate immune memory.
Rother N; Yanginlar C; Prévot G; Jonkman I; Jacobs M; van Leent MMT; van Heck J; Matzaraki V; Azzun A; Morla-Folch J; Ranzenigo A; Wang W; van der Meel R; Fayad ZA; Riksen NP; Hilbrands LB; Lindeboom RGH; Martens JHA; Vermeulen M; Joosten LAB; Netea MG; Mulder WJM; van der Vlag J; Teunissen AJP; Duivenvoorden R
Cell Rep; 2023 Dec; 42(12):113458. PubMed ID: 37995184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
